Virginia's first NCI comprehensive centre (2021), a leader in melanoma peptide vaccines and therapeutic focused ultrasound.
NCI-designated in 1987, UVA became Virginia's first comprehensive cancer centre in 2021 and serves Charlottesville and the Appalachian south-west of the state. Craig Slingluff's decades of melanoma peptide vaccine trials made UVA a reference site for cancer vaccine immunology, complemented by Timothy Bullock's T-cell work. UVA is one of the world's leading centres for therapeutic focused ultrasound, with the Focused Ultrasound Foundation based in Charlottesville and trials in tumour ablation and immune priming. Director Thomas Loughran is the leading authority on large granular lymphocytic leukaemia, and the centre has a busy transplant and haematology service.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, including child institutions. 603 works · 10,036 citations · 66% open access · 18% clinical trials · 1% reviews.
Shares Insightec, Focused ultrasound & histotripsy, Melanoma.
Shares Insightec, Focused-ultrasound blood-brain barrier opening, Focused ultrasound & histotripsy.
Shares Histotripsy as an immune primer, Focused ultrasound & histotripsy.
Shares NCI-Designated Cancer Centers, Off-the-shelf cancer vaccines, National Cancer Institute (NIH), Melanoma.
Shares Insightec, Focused-ultrasound blood-brain barrier opening.
Shares NCI-Designated Cancer Centers, Off-the-shelf cancer vaccines, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Melanoma.
Shares Insightec, Focused-ultrasound blood-brain barrier opening.